Figure 2
Figure 2. Nifuroxazide inhibits STAT3, Jak2, and Tyk2 tyrosine phosphorylation. (A) U266 cells were incubated with the indicated concentration of nifuroxazide for 24 hours, after which whole-cell lysates were prepared, and Western blot analysis was performed using antibodies specific for tyrosine-phosphorylated STAT3 (p-tyr STAT3) and total STAT3. (B) U266 cells were incubated for the indicated times with 10 μM nifuroxazide. Western blots were performed for tyrosine-phosphorylated STAT3, serine-phosphorylated STAT3 (p-ser STAT3), and total STAT3. (C) INA6 cells were incubated with 10 μM nifuroxazide or vehicle for 6 hours, after which immunoprecipitation was performed followed by Western blotting with the indicated antibodies. Quantitation of bands is shown for each panel.

Nifuroxazide inhibits STAT3, Jak2, and Tyk2 tyrosine phosphorylation. (A) U266 cells were incubated with the indicated concentration of nifuroxazide for 24 hours, after which whole-cell lysates were prepared, and Western blot analysis was performed using antibodies specific for tyrosine-phosphorylated STAT3 (p-tyr STAT3) and total STAT3. (B) U266 cells were incubated for the indicated times with 10 μM nifuroxazide. Western blots were performed for tyrosine-phosphorylated STAT3, serine-phosphorylated STAT3 (p-ser STAT3), and total STAT3. (C) INA6 cells were incubated with 10 μM nifuroxazide or vehicle for 6 hours, after which immunoprecipitation was performed followed by Western blotting with the indicated antibodies. Quantitation of bands is shown for each panel.

Close Modal

or Create an Account

Close Modal
Close Modal